GETI-B.ST Getinge AB (publ)
Company Analysis
Latest News
Getinge Wins Analyst Price-Target Hikes After Strong Q3, as Margins Improve
On October 22, 2026, the day after Getinge AB released its third-quarter report, several financial institutions raised their price targets for the medical...
Getinge Wins FDA Clearance for Neonatal Catheter; AQR Discloses 0.50% Short Position
Getinge has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new 6Fr/48 cm Edi catheter, the company’s smallest Edi catheter....
Getinge's Q2 Beat Sends Shares Soaring 14% — But How Much of That Margin Miracle Was a One-Time Tariff Windfall?
Shares of Swedish medtech firm Getinge AB surged 14.1% to SEK 235.70 on July 18 after second-quarter results blew past expectations, raising a pointed...
Getinge Stock Surges 10% Following Q2 Beat, Margin Expansion
Getinge AB shares rallied over 10% after second-quarter 2026 results exceeded analyst expectations. The medical technology firm reported organic net sales...
🟢 Getinge is trading 10.3% up
Getinge is trading at SEK 232.80, up 10.3% from a comparison close of SEK 211.10 during regular trading. This is a price-action follow-up, so a separate...
🟢 Getinge is trading 7% up today on broad healthcare sector rally
Getinge is trading 7% up today at SEK 225.90 on a broad healthcare sector rally fueled by strong peer earnings. • The stock is trading significantly above its...